Vericel CorporationVCELNASDAQ
Loading
R&D Expense Growth TrendStable
Percentile Rank77
3Y CAGR+55.4%
5Y CAGR+16.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+55.4%/yr
Quarterly compound
5Y CAGR
+16.0%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 14.80% |
| Q3 2025 | -6.14% |
| Q2 2025 | -7.30% |
| Q1 2025 | 47.49% |
| Q4 2024 | -19.20% |
| Q3 2024 | -17.25% |
| Q2 2024 | 14.72% |
| Q1 2024 | 30.95% |
| Q4 2023 | -13.65% |
| Q3 2023 | 8.05% |
| Q2 2023 | 0.79% |
| Q1 2023 | -0.63% |
| Q4 2022 | 3.94% |
| Q3 2022 | 5.30% |
| Q2 2022 | -1.40% |
| Q1 2022 | 23.85% |
| Q4 2021 | -8.40% |
| Q3 2021 | -3.71% |
| Q2 2021 | 22.56% |
| Q1 2021 | 16.42% |
| Q4 2020 | 7.04% |
| Q3 2020 | -9.70% |
| Q2 2020 | -14.27% |
| Q1 2020 | 16.97% |
| Q4 2019 | 3.91% |
| Q3 2019 | -85.31% |
| Q2 2019 | 600.47% |
| Q1 2019 | -0.33% |
| Q4 2018 | -3.05% |
| Q3 2018 | -16.74% |
| Q2 2018 | 0.27% |
| Q1 2018 | 3.96% |
| Q4 2017 | 22.88% |
| Q3 2017 | -1.75% |
| Q2 2017 | -14.31% |
| Q1 2017 | -18.58% |
| Q4 2016 | 23.67% |
| Q3 2016 | -15.16% |
| Q2 2016 | 14.76% |
| Q1 2016 | -52.24% |